Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check2 days agoChange DetectedThe page history shows a new revision entry (v3.6.6) with added sections for Contacts/Locations and Study Status, and the preceding revision (v3.6.5) was removed. This reflects an update to the history-tracking UI and versioning metadata rather than substantive study data changes.SummaryDifference0.1%

- Check9 days agoChange DetectedRecent history entries document updated Study Status and Contacts/Locations for August 2026 (versions 256–258), with an older August 13 entry removed.SummaryDifference0.2%

- Check16 days agoChange DetectedNew history entries were added for versions 254 (2026-08-07) and 255 (2026-08-12), and the 2026-08-13 update adds the Study Status and Contacts/Locations sections to the record history; an earlier entry from 2026-08-05 was removed.SummaryDifference0.1%

- Check23 days agoChange DetectedVersion 3.6.5 was added on 2026-08-05, introducing updates to the Study Status and Contacts/Locations sections. The history also records **Revision: v3.6.5** and removes the prior **Revision: v3.6.4** entry.SummaryDifference0.2%

- Check31 days agoChange DetectedThe latest version updates the study title to 'Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)' and adds key sections (Contacts/Locations, Eligibility, Study Status, Study Identification). It also removes the previous title entry from 2026-07-16.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a platform-level update to the page rather than a modification to study content or history data.SummaryDifference0.0%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.